

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, classical pathway (GO:0006958) | 9.83167565 |
| 2 | diterpenoid biosynthetic process (GO:0016102) | 9.31904313 |
| 3 | complement activation (GO:0006956) | 7.62535922 |
| 4 | keratinocyte development (GO:0003334) | 7.36027266 |
| 5 | positive regulation of respiratory burst (GO:0060267) | 6.73472368 |
| 6 | terpenoid biosynthetic process (GO:0016114) | 6.20907929 |
| 7 | mammary gland epithelial cell proliferation (GO:0033598) | 5.93720787 |
| 8 | glomerular filtration (GO:0003094) | 5.59963215 |
| 9 | ear development (GO:0043583) | 5.58804816 |
| 10 | protein activation cascade (GO:0072376) | 5.55828762 |
| 11 | renal filtration (GO:0097205) | 5.01188705 |
| 12 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.01176494 |
| 13 | regulation of respiratory burst (GO:0060263) | 4.80968040 |
| 14 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 4.69621426 |
| 15 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 4.56377092 |
| 16 | Fc-gamma receptor signaling pathway (GO:0038094) | 4.56377092 |
| 17 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 4.56377092 |
| 18 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 4.52165711 |
| 19 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.45891734 |
| 20 | regulation of cellular extravasation (GO:0002691) | 4.43903809 |
| 21 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.38812146 |
| 22 | humoral immune response (GO:0006959) | 4.32858834 |
| 23 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.29059997 |
| 24 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.23538324 |
| 25 | trophectodermal cell differentiation (GO:0001829) | 4.18857003 |
| 26 | antibacterial humoral response (GO:0019731) | 4.11037650 |
| 27 | positive regulation of cellular response to oxidative stress (GO:1900409) | 4.09909332 |
| 28 | positive regulation of response to oxidative stress (GO:1902884) | 4.09909332 |
| 29 | antimicrobial humoral response (GO:0019730) | 3.96910742 |
| 30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.94414481 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.92209660 |
| 32 | retina homeostasis (GO:0001895) | 3.76036965 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.67704616 |
| 34 | retinal metabolic process (GO:0042574) | 3.66536507 |
| 35 | regulation of receptor recycling (GO:0001919) | 3.55032720 |
| 36 | embryonic viscerocranium morphogenesis (GO:0048703) | 3.53671915 |
| 37 | regulation of vitamin metabolic process (GO:0030656) | 3.52019310 |
| 38 | NIK/NF-kappaB signaling (GO:0038061) | 3.50519793 |
| 39 | branch elongation of an epithelium (GO:0060602) | 3.49919866 |
| 40 | regulation of antigen processing and presentation (GO:0002577) | 3.34750031 |
| 41 | embryonic camera-type eye development (GO:0031076) | 3.28998017 |
| 42 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.11376713 |
| 43 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.11329245 |
| 44 | immunoglobulin mediated immune response (GO:0016064) | 3.08247807 |
| 45 | retinoic acid metabolic process (GO:0042573) | 3.07150099 |
| 46 | positive regulation of receptor recycling (GO:0001921) | 3.06841295 |
| 47 | polyamine biosynthetic process (GO:0006596) | 3.06634128 |
| 48 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.02431079 |
| 49 | lymph node development (GO:0048535) | 3.01966546 |
| 50 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.99141924 |
| 51 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.96825946 |
| 52 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.95840208 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.94285217 |
| 54 | positive regulation of interferon-alpha production (GO:0032727) | 2.93437707 |
| 55 | regulation of keratinocyte proliferation (GO:0010837) | 2.90322548 |
| 56 | ER overload response (GO:0006983) | 2.86787548 |
| 57 | negative regulation of complement activation (GO:0045916) | 2.85651746 |
| 58 | morphogenesis of an epithelial fold (GO:0060571) | 2.79810357 |
| 59 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.77159058 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76964238 |
| 61 | regulation of bile acid biosynthetic process (GO:0070857) | 2.71765026 |
| 62 | production of molecular mediator of immune response (GO:0002440) | 2.70677271 |
| 63 | regulation of interferon-alpha production (GO:0032647) | 2.70240388 |
| 64 | blood vessel maturation (GO:0001955) | 2.69132150 |
| 65 | B cell mediated immunity (GO:0019724) | 2.68640988 |
| 66 | response to hydroperoxide (GO:0033194) | 2.66657839 |
| 67 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66317809 |
| 68 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.65294993 |
| 69 | regulation of T cell migration (GO:2000404) | 2.65183646 |
| 70 | nucleotide transmembrane transport (GO:1901679) | 2.64498207 |
| 71 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.63478078 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.62402737 |
| 73 | skin morphogenesis (GO:0043589) | 2.61997571 |
| 74 | amyloid precursor protein catabolic process (GO:0042987) | 2.60766380 |
| 75 | negative regulation of humoral immune response (GO:0002921) | 2.58719098 |
| 76 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.56527629 |
| 77 | type I interferon signaling pathway (GO:0060337) | 2.56516703 |
| 78 | cellular response to type I interferon (GO:0071357) | 2.56516703 |
| 79 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.56468127 |
| 80 | response to type I interferon (GO:0034340) | 2.54433166 |
| 81 | angiotensin maturation (GO:0002003) | 2.54384271 |
| 82 | peptide catabolic process (GO:0043171) | 2.54108103 |
| 83 | intestinal absorption (GO:0050892) | 2.54078103 |
| 84 | superoxide anion generation (GO:0042554) | 2.51812432 |
| 85 | negative regulation of protein activation cascade (GO:2000258) | 2.48854404 |
| 86 | retinol metabolic process (GO:0042572) | 2.47825631 |
| 87 | regulation of guanylate cyclase activity (GO:0031282) | 2.46114839 |
| 88 | fructose metabolic process (GO:0006000) | 2.45138547 |
| 89 | regulation of regulatory T cell differentiation (GO:0045589) | 2.43891958 |
| 90 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.40506710 |
| 91 | immune response-activating signal transduction (GO:0002757) | 2.39970222 |
| 92 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.39478416 |
| 93 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.38803923 |
| 94 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.38186822 |
| 95 | regulation of RNA export from nucleus (GO:0046831) | 2.37644876 |
| 96 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.35311248 |
| 97 | organ formation (GO:0048645) | 2.34126288 |
| 98 | I-kappaB phosphorylation (GO:0007252) | 2.32294522 |
| 99 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.32088954 |
| 100 | receptor catabolic process (GO:0032801) | 2.31189819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 6.99760665 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.95498561 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.60559543 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.34126178 |
| 5 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.15899263 |
| 6 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.98331020 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.86845957 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.62023339 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.53990469 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53971041 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.42061338 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.25218395 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.23885708 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.14590084 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.11192223 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.10833381 |
| 17 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.10394293 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.01312703 |
| 19 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.00518953 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.94836895 |
| 21 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.93913065 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.92694684 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.89862779 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.89402440 |
| 25 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.86867378 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.85099166 |
| 27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.80502433 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74605265 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68864457 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64318139 |
| 31 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.61731765 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61531830 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58311714 |
| 34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.57704265 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.48195453 |
| 36 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.41491667 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40366966 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38382345 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.36909880 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33191299 |
| 41 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27999419 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.27734170 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27195137 |
| 44 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27103715 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26804125 |
| 46 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26235900 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25342873 |
| 48 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.24767951 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22522812 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22384124 |
| 51 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.20088670 |
| 52 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.19610631 |
| 53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15527608 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.12364075 |
| 55 | CJUN_26792858_Chip-Seq_BT549_Human | 1.11633651 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11463330 |
| 57 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09673202 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07700336 |
| 59 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07004090 |
| 60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06269410 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05368071 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04489791 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03963724 |
| 64 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02442129 |
| 65 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02442129 |
| 66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02226468 |
| 67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01898803 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01341497 |
| 69 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01129697 |
| 70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00123056 |
| 71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99685320 |
| 72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99576569 |
| 73 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98701175 |
| 74 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98349448 |
| 75 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97400663 |
| 76 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94706171 |
| 77 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94215596 |
| 78 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93693457 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93615300 |
| 80 | MAF_26560356_Chip-Seq_TH1_Human | 0.93504232 |
| 81 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93204836 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91183686 |
| 83 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.91076994 |
| 84 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.88237579 |
| 85 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.87975575 |
| 86 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87362122 |
| 87 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85659849 |
| 88 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83751357 |
| 89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.83438895 |
| 90 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82460435 |
| 91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82328508 |
| 92 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81449667 |
| 93 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81016393 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80966411 |
| 95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80774520 |
| 96 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.80665232 |
| 97 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.80637997 |
| 98 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.80576574 |
| 99 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.80418366 |
| 100 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.80171152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 6.58388104 |
| 2 | MP0003828_pulmonary_edema | 4.61304789 |
| 3 | MP0005670_abnormal_white_adipose | 2.86180602 |
| 4 | MP0010155_abnormal_intestine_physiology | 2.82804408 |
| 5 | MP0000427_abnormal_hair_cycle | 2.79338494 |
| 6 | MP0003724_increased_susceptibility_to | 2.51849544 |
| 7 | MP0003183_abnormal_peptide_metabolism | 2.46709025 |
| 8 | MP0001800_abnormal_humoral_immune | 2.44126606 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.34129847 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.30871387 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.27076630 |
| 12 | MP0003221_abnormal_cardiomyocyte_apopto | 2.16987116 |
| 13 | MP0000465_gastrointestinal_hemorrhage | 2.15093275 |
| 14 | MP0002796_impaired_skin_barrier | 2.07945328 |
| 15 | MP0004264_abnormal_extraembryonic_tissu | 1.98566521 |
| 16 | MP0003252_abnormal_bile_duct | 1.98163437 |
| 17 | MP0000685_abnormal_immune_system | 1.97040901 |
| 18 | MP0001790_abnormal_immune_system | 1.92470083 |
| 19 | MP0005387_immune_system_phenotype | 1.92470083 |
| 20 | MP0004782_abnormal_surfactant_physiolog | 1.81377600 |
| 21 | MP0004947_skin_inflammation | 1.81122283 |
| 22 | MP0000467_abnormal_esophagus_morphology | 1.79015462 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.76766943 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.76342602 |
| 25 | MP0002452_abnormal_antigen_presenting | 1.75493883 |
| 26 | MP0005025_abnormal_response_to | 1.67279865 |
| 27 | MP0006054_spinal_hemorrhage | 1.62580217 |
| 28 | MP0003866_abnormal_defecation | 1.61096386 |
| 29 | MP0003303_peritoneal_inflammation | 1.60265149 |
| 30 | MP0002254_reproductive_system_inflammat | 1.59849455 |
| 31 | MP0009785_altered_susceptibility_to | 1.58642377 |
| 32 | MP0000377_abnormal_hair_follicle | 1.58222437 |
| 33 | MP0003329_amyloid_beta_deposits | 1.56767880 |
| 34 | MP0003436_decreased_susceptibility_to | 1.56426938 |
| 35 | MP0001243_abnormal_dermal_layer | 1.51043274 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.50541089 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.48214171 |
| 38 | MP0002723_abnormal_immune_serum | 1.46707447 |
| 39 | MP0005310_abnormal_salivary_gland | 1.41478488 |
| 40 | MP0005671_abnormal_response_to | 1.40213160 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.39117453 |
| 42 | MP0005164_abnormal_response_to | 1.37222678 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.36640455 |
| 44 | MP0001819_abnormal_immune_cell | 1.36181847 |
| 45 | MP0010307_abnormal_tumor_latency | 1.36019645 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.30457627 |
| 47 | MP0000627_abnormal_mammary_gland | 1.25952239 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.25632524 |
| 49 | MP0001216_abnormal_epidermal_layer | 1.22896227 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.19979575 |
| 51 | MP0000604_amyloidosis | 1.19799541 |
| 52 | MP0002133_abnormal_respiratory_system | 1.19792879 |
| 53 | MP0005388_respiratory_system_phenotype | 1.19792879 |
| 54 | MP0005166_decreased_susceptibility_to | 1.19777534 |
| 55 | MP0001873_stomach_inflammation | 1.18962792 |
| 56 | MP0005165_increased_susceptibility_to | 1.15428371 |
| 57 | MP0005275_abnormal_skin_tensile | 1.14930961 |
| 58 | MP0001853_heart_inflammation | 1.13474298 |
| 59 | MP0002419_abnormal_innate_immunity | 1.12986359 |
| 60 | MP0003938_abnormal_ear_development | 1.12783858 |
| 61 | MP0006082_CNS_inflammation | 1.11599508 |
| 62 | MP0002136_abnormal_kidney_physiology | 1.11472737 |
| 63 | MP0000716_abnormal_immune_system | 1.10254507 |
| 64 | MP0001881_abnormal_mammary_gland | 1.10013846 |
| 65 | MP0000470_abnormal_stomach_morphology | 1.09518346 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.08923328 |
| 67 | MP0003091_abnormal_cell_migration | 1.06507144 |
| 68 | MP0000749_muscle_degeneration | 1.00728022 |
| 69 | MP0002098_abnormal_vibrissa_morphology | 1.00017408 |
| 70 | MP0002006_tumorigenesis | 0.99156181 |
| 71 | MP0000477_abnormal_intestine_morphology | 0.98800907 |
| 72 | MP0010678_abnormal_skin_adnexa | 0.97160013 |
| 73 | MP0003787_abnormal_imprinting | 0.96456010 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.92274957 |
| 75 | MP0000490_abnormal_crypts_of | 0.92180484 |
| 76 | MP0001764_abnormal_homeostasis | 0.91097249 |
| 77 | MP0003075_altered_response_to | 0.89574648 |
| 78 | MP0002405_respiratory_system_inflammati | 0.89357942 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 0.88371982 |
| 80 | MP0001756_abnormal_urination | 0.87143153 |
| 81 | MP0001502_abnormal_circadian_rhythm | 0.86196363 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85956595 |
| 83 | MP0004858_abnormal_nervous_system | 0.85683259 |
| 84 | MP0002398_abnormal_bone_marrow | 0.85259154 |
| 85 | MP0002060_abnormal_skin_morphology | 0.84987045 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 0.84017783 |
| 87 | MP0005058_abnormal_lysosome_morphology | 0.83715163 |
| 88 | MP0001663_abnormal_digestive_system | 0.83564703 |
| 89 | MP0002896_abnormal_bone_mineralization | 0.82844960 |
| 90 | MP0003763_abnormal_thymus_physiology | 0.82095641 |
| 91 | MP0005365_abnormal_bile_salt | 0.81805484 |
| 92 | MP0008469_abnormal_protein_level | 0.80622680 |
| 93 | MP0003448_altered_tumor_morphology | 0.79587303 |
| 94 | MP0000647_abnormal_sebaceous_gland | 0.78123777 |
| 95 | MP0000609_abnormal_liver_physiology | 0.77134872 |
| 96 | MP0002429_abnormal_blood_cell | 0.76268703 |
| 97 | MP0003936_abnormal_reproductive_system | 0.75780612 |
| 98 | MP0001533_abnormal_skeleton_physiology | 0.75474538 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.73978642 |
| 100 | MP0000689_abnormal_spleen_morphology | 0.73940554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Axonal loss (HP:0003447) | 8.50426957 |
| 2 | Diaphragmatic weakness (HP:0009113) | 6.78045242 |
| 3 | Febrile seizures (HP:0002373) | 6.65653354 |
| 4 | Alopecia of scalp (HP:0002293) | 5.92997031 |
| 5 | Abnormality of the frontal sinuses (HP:0002687) | 5.18497740 |
| 6 | Abnormality of dental color (HP:0011073) | 5.08652733 |
| 7 | Amelogenesis imperfecta (HP:0000705) | 4.65351851 |
| 8 | Hyperactive renin-angiotensin system (HP:0000841) | 4.34808110 |
| 9 | Follicular hyperkeratosis (HP:0007502) | 3.97499271 |
| 10 | Fragile nails (HP:0001808) | 3.86021394 |
| 11 | Sparse lateral eyebrow (HP:0005338) | 3.66054222 |
| 12 | Woolly hair (HP:0002224) | 3.64086767 |
| 13 | Decreased circulating renin level (HP:0003351) | 3.60873717 |
| 14 | Malnutrition (HP:0004395) | 3.52541948 |
| 15 | Easy fatigability (HP:0003388) | 3.44476531 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.44219686 |
| 17 | Spinal rigidity (HP:0003306) | 3.22634106 |
| 18 | Tubulointerstitial nephritis (HP:0001970) | 3.17116041 |
| 19 | Generalized amyotrophy (HP:0003700) | 3.03458022 |
| 20 | Recurrent bronchitis (HP:0002837) | 3.00017224 |
| 21 | Prostate neoplasm (HP:0100787) | 2.94672219 |
| 22 | Abnormality of secondary sexual hair (HP:0009888) | 2.92288132 |
| 23 | Abnormality of the axillary hair (HP:0100134) | 2.92288132 |
| 24 | Alveolar cell carcinoma (HP:0006519) | 2.86382497 |
| 25 | Abnormality of the dental root (HP:0006486) | 2.81943811 |
| 26 | Taurodontia (HP:0000679) | 2.81943811 |
| 27 | Abnormality of permanent molar morphology (HP:0011071) | 2.81943811 |
| 28 | Nasal speech (HP:0001611) | 2.80252060 |
| 29 | Rapidly progressive (HP:0003678) | 2.80147130 |
| 30 | Autoimmune hemolytic anemia (HP:0001890) | 2.75694619 |
| 31 | Abnormality of molar morphology (HP:0011070) | 2.75389781 |
| 32 | Abnormality of molar (HP:0011077) | 2.75389781 |
| 33 | Eczematoid dermatitis (HP:0000976) | 2.75036044 |
| 34 | Recurrent abscess formation (HP:0002722) | 2.74240737 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 2.73828006 |
| 36 | Abnormality of the dental pulp (HP:0006479) | 2.68023137 |
| 37 | Craniofacial hyperostosis (HP:0004493) | 2.61028832 |
| 38 | Aplasia of the musculature (HP:0100854) | 2.59545420 |
| 39 | Vasculitis (HP:0002633) | 2.59169774 |
| 40 | Disinhibition (HP:0000734) | 2.51086815 |
| 41 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.50957871 |
| 42 | Abnormality of renin-angiotensin system (HP:0000847) | 2.50025680 |
| 43 | Abnormality of macrophages (HP:0004311) | 2.48509745 |
| 44 | Generalized tonic-clonic seizures (HP:0002069) | 2.45710162 |
| 45 | Chronic diarrhea (HP:0002028) | 2.44542442 |
| 46 | Glomerulonephritis (HP:0000099) | 2.42250270 |
| 47 | Bronchitis (HP:0012387) | 2.41872764 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.38548266 |
| 49 | Right ventricular cardiomyopathy (HP:0011663) | 2.36156971 |
| 50 | Abnormality of complement system (HP:0005339) | 2.35147558 |
| 51 | Recurrent viral infections (HP:0004429) | 2.34201034 |
| 52 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.33052854 |
| 53 | Conjunctival telangiectasia (HP:0000524) | 2.30940089 |
| 54 | Hyperkalemia (HP:0002153) | 2.30105571 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.29818296 |
| 56 | Cranial hyperostosis (HP:0004437) | 2.29384205 |
| 57 | Abnormal tarsal ossification (HP:0008369) | 2.27332715 |
| 58 | Abnormality of the prostate (HP:0008775) | 2.26975716 |
| 59 | Amyotrophic lateral sclerosis (HP:0007354) | 2.26761513 |
| 60 | EMG: myopathic abnormalities (HP:0003458) | 2.25273977 |
| 61 | Abnormality of the gastric mucosa (HP:0004295) | 2.21784299 |
| 62 | Blepharitis (HP:0000498) | 2.20119777 |
| 63 | Complement deficiency (HP:0004431) | 2.16196284 |
| 64 | Premature loss of primary teeth (HP:0006323) | 2.14981559 |
| 65 | Alkalosis (HP:0001948) | 2.14136611 |
| 66 | Lip pit (HP:0100267) | 2.13517261 |
| 67 | Knee flexion contracture (HP:0006380) | 2.09170563 |
| 68 | Spontaneous hematomas (HP:0007420) | 2.08812184 |
| 69 | Hyperparathyroidism (HP:0000843) | 2.08699419 |
| 70 | Neoplasm of the lung (HP:0100526) | 2.07987205 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.07856854 |
| 72 | Hyperaldosteronism (HP:0000859) | 2.07593402 |
| 73 | Gastrointestinal stroma tumor (HP:0100723) | 2.05430138 |
| 74 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.99913821 |
| 75 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99184116 |
| 76 | Flat acetabular roof (HP:0003180) | 1.98189157 |
| 77 | Abnormality of chloride homeostasis (HP:0011422) | 1.97960559 |
| 78 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95291697 |
| 79 | Obstructive lung disease (HP:0006536) | 1.95291697 |
| 80 | Hypokalemic alkalosis (HP:0001949) | 1.94551369 |
| 81 | Exocrine pancreatic insufficiency (HP:0001738) | 1.92013290 |
| 82 | Autoimmune thrombocytopenia (HP:0001973) | 1.89726846 |
| 83 | Nephritis (HP:0000123) | 1.88778333 |
| 84 | Abnormality of B cell number (HP:0010975) | 1.81255608 |
| 85 | Seborrheic dermatitis (HP:0001051) | 1.80017435 |
| 86 | Hemoptysis (HP:0002105) | 1.79735317 |
| 87 | Pulmonary infiltrates (HP:0002113) | 1.78161842 |
| 88 | Meningitis (HP:0001287) | 1.76710295 |
| 89 | Adrenal overactivity (HP:0002717) | 1.75760689 |
| 90 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.74283900 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 1.73303590 |
| 92 | Osteomyelitis (HP:0002754) | 1.72873096 |
| 93 | Neoplasm of the respiratory system (HP:0100606) | 1.72510365 |
| 94 | Metabolic alkalosis (HP:0200114) | 1.72135840 |
| 95 | Renal salt wasting (HP:0000127) | 1.71864888 |
| 96 | Tubular atrophy (HP:0000092) | 1.70788563 |
| 97 | Colitis (HP:0002583) | 1.68290866 |
| 98 | Lower limb hyperreflexia (HP:0002395) | 1.68254219 |
| 99 | Hypertensive crisis (HP:0100735) | 1.67962518 |
| 100 | Erythema (HP:0010783) | 1.67609620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 7.95492094 |
| 2 | BMPR2 | 5.31211623 |
| 3 | AKT3 | 3.99431873 |
| 4 | STK39 | 3.98687208 |
| 5 | TESK2 | 3.27267344 |
| 6 | MAP3K12 | 3.14327374 |
| 7 | MAP3K14 | 3.05892463 |
| 8 | OXSR1 | 3.00026593 |
| 9 | TAF1 | 2.58846927 |
| 10 | TNIK | 2.23901644 |
| 11 | EIF2AK3 | 2.14912705 |
| 12 | MST1R | 2.05111339 |
| 13 | LATS2 | 2.02646975 |
| 14 | ERN1 | 2.00544145 |
| 15 | RIPK4 | 1.95655256 |
| 16 | SIK3 | 1.72880388 |
| 17 | FGFR4 | 1.53254739 |
| 18 | EIF2AK1 | 1.50883501 |
| 19 | PRPF4B | 1.41217811 |
| 20 | EPHA3 | 1.37208802 |
| 21 | ACVR1B | 1.28548201 |
| 22 | TYK2 | 1.25142612 |
| 23 | MAP4K1 | 1.24797391 |
| 24 | YES1 | 1.23971976 |
| 25 | MYLK | 1.14115294 |
| 26 | FGFR3 | 1.14033988 |
| 27 | CSK | 1.07592059 |
| 28 | DMPK | 1.07549421 |
| 29 | FER | 1.06716112 |
| 30 | EPHB1 | 1.06327580 |
| 31 | MAP3K1 | 1.04463544 |
| 32 | DYRK3 | 1.04238735 |
| 33 | BLK | 0.97713439 |
| 34 | TBK1 | 0.96802232 |
| 35 | TRIM28 | 0.94962703 |
| 36 | BRSK2 | 0.94782638 |
| 37 | PIK3CA | 0.93032587 |
| 38 | TGFBR2 | 0.81302070 |
| 39 | JAK1 | 0.80640499 |
| 40 | MATK | 0.78253508 |
| 41 | MAP2K2 | 0.72118027 |
| 42 | PIK3CG | 0.71980319 |
| 43 | MAP3K3 | 0.69644012 |
| 44 | EPHA2 | 0.68579136 |
| 45 | IKBKB | 0.67998009 |
| 46 | PAK4 | 0.67393507 |
| 47 | KIT | 0.66749562 |
| 48 | DYRK1A | 0.64565227 |
| 49 | NLK | 0.62738666 |
| 50 | IKBKE | 0.60462636 |
| 51 | FES | 0.59951237 |
| 52 | MAP3K2 | 0.57925418 |
| 53 | RAF1 | 0.55343824 |
| 54 | PDGFRB | 0.54296045 |
| 55 | JAK3 | 0.53420693 |
| 56 | RIPK1 | 0.52393561 |
| 57 | ZAP70 | 0.50849216 |
| 58 | LYN | 0.50691528 |
| 59 | MET | 0.50431718 |
| 60 | MST4 | 0.50029614 |
| 61 | SIK2 | 0.47010596 |
| 62 | PRKCD | 0.46936510 |
| 63 | EIF2AK2 | 0.45612034 |
| 64 | MAP4K2 | 0.44995519 |
| 65 | CDC42BPA | 0.44216112 |
| 66 | MAP2K1 | 0.41370242 |
| 67 | FRK | 0.41110913 |
| 68 | PRKG2 | 0.41006769 |
| 69 | MAP3K13 | 0.40749355 |
| 70 | MAP3K10 | 0.40202804 |
| 71 | IRAK1 | 0.39389816 |
| 72 | TXK | 0.39079731 |
| 73 | SYK | 0.38776420 |
| 74 | MAPKAPK3 | 0.38504444 |
| 75 | NUAK1 | 0.38139154 |
| 76 | TESK1 | 0.35551762 |
| 77 | PRKCQ | 0.33495032 |
| 78 | BRSK1 | 0.30755605 |
| 79 | PDGFRA | 0.29452637 |
| 80 | HIPK2 | 0.29316388 |
| 81 | JAK2 | 0.29055885 |
| 82 | CDK3 | 0.28603320 |
| 83 | PIM2 | 0.28262859 |
| 84 | DDR2 | 0.26788087 |
| 85 | MARK3 | 0.26146569 |
| 86 | IRAK4 | 0.24341716 |
| 87 | TAOK3 | 0.23040266 |
| 88 | MTOR | 0.21198721 |
| 89 | MKNK2 | 0.19748797 |
| 90 | SCYL2 | 0.18233568 |
| 91 | MAP3K11 | 0.17488542 |
| 92 | MAPKAPK2 | 0.17013325 |
| 93 | LRRK2 | 0.16247387 |
| 94 | PAK1 | 0.14606746 |
| 95 | EPHB2 | 0.14575434 |
| 96 | BCR | 0.13932029 |
| 97 | SRPK1 | 0.13292976 |
| 98 | KSR1 | 0.13249030 |
| 99 | BTK | 0.12429453 |
| 100 | GRK5 | 0.12251219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.17247948 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.27252832 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.90207134 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.87426491 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.75895263 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.68891840 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.61542763 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.32424396 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12055202 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.93583192 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90240513 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.79123855 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77463341 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.66514181 |
| 15 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.63821484 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61714930 |
| 17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.60506510 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56156331 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48934559 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.47901259 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40792178 |
| 22 | Mineral absorption_Homo sapiens_hsa04978 | 1.37163899 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32536859 |
| 24 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.32036782 |
| 25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29335853 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26725864 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.24507401 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21757566 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19319678 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.18434533 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16194486 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.15885106 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.14524621 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13302066 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.10939742 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10051965 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.08563821 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03878591 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03130934 |
| 40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.02348205 |
| 41 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.02285253 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.00616125 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99904222 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97501622 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95869751 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95053116 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95051919 |
| 48 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.94586118 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92922771 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.90842592 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.89391009 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84803550 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.84187551 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.83326068 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82107080 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79654145 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78177821 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78176215 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76824968 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.75863517 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75619132 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74573094 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74004466 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73612650 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71007053 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69952185 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.68374012 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67864931 |
| 69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67677549 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67120534 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66543922 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65448726 |
| 73 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.64444213 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62982454 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60756079 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58161780 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56746263 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54192576 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53905259 |
| 80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52380668 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.50948956 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50526296 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48296172 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46256770 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45542761 |
| 86 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45385943 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43883770 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42821535 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41221534 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37940867 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37762254 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37708205 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36526294 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.35289655 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35200543 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.35098139 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35053812 |
| 98 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.34834796 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33620819 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.33017029 |

